IORI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.249
EU - Europa 353
AS - Asia 284
OC - Oceania 6
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.897
Nazione #
US - Stati Uniti d'America 3.247
CN - Cina 216
IT - Italia 96
SE - Svezia 71
FI - Finlandia 57
DE - Germania 52
VN - Vietnam 49
GB - Regno Unito 36
UA - Ucraina 22
IN - India 12
IE - Irlanda 9
FR - Francia 6
AU - Australia 3
JP - Giappone 3
NL - Olanda 3
NZ - Nuova Zelanda 3
CA - Canada 2
EU - Europa 2
ID - Indonesia 2
NG - Nigeria 2
BG - Bulgaria 1
KE - Kenya 1
PK - Pakistan 1
TR - Turchia 1
Totale 3.897
Città #
Fairfield 548
Woodbridge 360
Chandler 332
Houston 283
Ashburn 226
Seattle 221
Cambridge 208
Ann Arbor 201
Wilmington 177
Jacksonville 118
San Diego 75
Princeton 69
Beijing 57
Dong Ket 49
Padova 45
Nanjing 41
Des Moines 35
Roxbury 34
Medford 27
Boardman 26
Helsinki 23
New York 20
Guangzhou 16
Jinan 10
Shenyang 10
Changsha 8
London 8
Hebei 7
Sommacampagna 7
Hefei 6
Kunming 6
Milan 6
Norwalk 6
Shanghai 6
Tianjin 6
Dearborn 5
Jiaxing 5
Selvazzano Dentro 5
Zhengzhou 5
Dublin 4
Ningbo 4
Paris 4
Tappahannock 4
Venice 4
Chicago 3
Detroit 3
Hangzhou 3
Nanchang 3
Sutton 3
Borås 2
Chongqing 2
Hounslow 2
Nürnberg 2
Ogden 2
Pinehaven 2
Redwood City 2
Rome 2
Salerno 2
Vicenza 2
Wuhan 2
Auckland 1
Bochum 1
Bologna 1
Brescia 1
Castel Maggiore 1
Cento 1
Charleston 1
Chiaravalle 1
Chiswick 1
Ergolding 1
Esslingen am Neckar 1
Falls Church 1
Ferentino 1
Fuzhou 1
Gunzenhausen 1
Haikou 1
Huzhou 1
Islington 1
Jakarta 1
Kilburn 1
Lanzhou 1
Leawood 1
Los Angeles 1
Mardan 1
Mazzarino 1
Melbourne 1
Montréal 1
Phoenix 1
Piove Di Sacco 1
Prescot 1
Pune 1
Reading 1
Redmond 1
Richmond 1
Rockville 1
San Francisco 1
San Mateo 1
Shaoxing 1
Surabaya 1
Sydney 1
Totale 3.394
Nome #
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 187
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 151
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 145
Delta2D and Proteomweaver: Performance evaluation of two different approaches for 2-DE analysis 139
Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy 137
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 124
Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. 117
The inter- and intra-operator variability in manual spot segmentation and its effect on spot quantitation in two-dimensional electrophoresis analysis. 110
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 109
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 109
Lumican is overexpressed in lung adenocarcinoma pleural effusions. 105
Improved instrumentation for large-size two-dimensional protein maps 102
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population. 101
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 100
Caldesmon over-expression in type 1 diabetic nephropathy 99
Rapid, simple and effective technical procedure for the regeneration of IgG and HSA affinity columns for proteomic analysis. 95
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 92
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 91
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 90
Effects of CK2 inhibition in cultured fibroblasts from Type 1 Diabetic patients with or without nephropathy 88
Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects 87
Systemic and vascular inflammation in an in-vitro model of central obesity 87
SDS-PAGE and two-dimensional maps in a radial gel format. 86
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: A randomized placebo-controlled trial 85
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 82
Evidence for acute stimulation of fibrinogen production by glucagon in humans. 81
No peptide left behind: the "out of range" recovery in IPG-IEF fractionation. 81
The Transcriptional Response in Human Umbilical Vein Endothelial Cells Exposed to Insulin: a Dynamic Gene Expression Approach. 80
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 80
Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. 77
The Effects of Rosiglitazone and High Glucose on Protein Expression in Endothelial Cells 70
Reduced in vivo biological activity of in vitro glycosylated insulin. 68
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 67
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 66
Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. 62
Hyperglucagonemia stimulates phenylalanine oxidation in man. 58
Effect of Reversal of the Whey protein to casein ratio of cow milk on insulin and incretin responses in humans 58
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor 53
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 48
Abnormal calcium release by angiotensin II and growth rate in skin fibroblasts from type 1 diabetic patients with diabetic nephropathy. 45
Effect of reversal of whey-protein to casein ratio of cow milk, on insulin, incretin and amino acid responses in humans 44
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 42
Neither Incretin or Amino Acid Responses, nor Casein Content, Account for the Equal Insulin Response Following Iso-Lactose Loads of Natural Human and Cow Milk in Healthy Young Adults 35
Function-based discovery of characteristic temporal expression profiles in endothelial cells stimulated with insulin. 34
Modulatory effect of insulin on calcium release by ANG II in human fibroblasts 29
A novel MRPS34 gene mutation with combined OXPHOS deficiency in an adult patient with Leigh syndrome 28
Barikot, Swat: Excavation Campaign 2021-2022, Preliminary Report. Trenches BKG 16, BKG 17, and BKG 18 13
Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy 3
Increased Soluble Interleukin 6 Receptors in Fabry Disease 3
Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a 1
Totale 3.944
Categoria #
all - tutte 13.270
article - articoli 13.029
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 118
Totale 26.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019341 0 0 0 0 0 0 0 0 0 70 135 136
2019/2020862 105 31 24 80 84 75 110 87 90 102 41 33
2020/2021702 26 33 14 78 54 66 49 43 98 58 76 107
2021/2022710 10 87 103 30 37 65 39 57 44 26 88 124
2022/2023580 110 77 11 81 87 72 1 46 56 11 21 7
2023/2024226 11 42 44 27 16 37 20 10 7 12 0 0
Totale 3.944